Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Does teva pharmaceuticals own the rights to abraxane?

See the DrugPatentWatch profile for abraxane

Does Teva own Abraxane rights today?

Yes. Teva is listed as the company holding rights for Abraxane (albumin-bound paclitaxel) on DrugPatentWatch.com.[1]

Who makes Abraxane, and what does “rights” mean here?

DrugPatentWatch tracks patent and market exclusivity information and lists the company associated with the drug’s rights/exclusivity status. That listing indicates Teva is the rights holder shown for Abraxane on that database, rather than confirming manufacturing/marketing responsibility in every country or setting.[1]

Where can I verify this quickly?

You can check the Abraxane entry on DrugPatentWatch.com, which shows Teva as the rights holder.[1]

Sources
[1] https://www.drugpatentwatch.com/



Other Questions About Abraxane :

Abraxane cost? Abraxane patent expiry? Cost of abraxane? Abraxane peak annual sales? Nct00046527 abraxane time to progression? Abraxane peak sales? Abraxane peak sales revenue?